Ireland· IE-PA-EU/1/20/1496/001
Oxlumo 94.5 mg/0.5 mL solution for injection
A various alimentary tract and metabolism products product containing lumasiran sodium, registered in Ireland by Alnylam Netherlands B.V.. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Lumasiran sodium is registered in 4 of 19 countries.
Countries holding a registration under ATC A16AX (various alimentary tract and metabolism products), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Lumasiran sodium · ATC A16AX
4 / 19 countries
- Finlandprice
- Ireland
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Lumasiran sodium
- Manufacturer
- Alnylam Netherlands B.V.
- Country
- Ireland (IE)
- ATC code
- A16AX
- ATC class
- Various alimentary tract and metabolism products
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/20/1496/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lumasiran sodium in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa0681a9-469d-4904-8c6d-75786d161680 GET /v1/drugs/aa0681a9-469d-4904-8c6d-75786d161680?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"A16AX"
],
"strength": null,
"pa_number": "EU/1/20/1496/001",
"substances": [
"Lumasiran sodium"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "19/11/2020",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about lumasiran sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.